Key result
Streptokinase therapy in acute myocardial infarction may cause allergic reactions that typically resolve without complications when promptly recognized and managed.
Physicians administering streptokinase for acute myocardial infarction must be vigilant for allergic reactions, which typically resolve with prompt management.
Answers are grounded in this paper and cite their sources.
Highlights need for monitoring allergic reactions to streptokinase in AMI; leaves open updated incidence data in contemporary practice.
Streptokinase is an important component in the treatment strategy for acute myocardial infarction. However, physicians need to be aware that some patients may experience allergic reactions to this drug. Prompt recognition and appropriate management of symptoms usually result in recovery from the allergic event without further complication.
No takes yet. Share an insight, caveat, or question.
Stephens et al. (1998) studied this question. Streptokinase therapy in acute myocardial infarction may cause allergic reactions that typically resolve without complications when promptly recognized and managed.
Synapse has enriched 10 related papers. Consider them for comparative context: